RBC Life Science and Technology Fund

You are on: FUND INDIVIDUAL page

Select Series:
Select Another Fund:

Marcello Montanari

Profile >

Rob Cavallo

Profile >

Investment Objective

To provide long-term capital growth by investing primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances.

Fund Details

Series: A
Fund Code: RBF274
Load Structure: No Load
Currency: CAD
Inception Date: Jul, 1995
Series A NAV $: 15.08
Series A MER %: 2.20
Adjusted A MER %: 2.09
Benchmark:
  • 50% S&P 500 Health Care Index ($C)
  • 50% S&P 500 Information Technology Index ($C)


  • Income Distribution: Annually
    Capital Gains Distribution: Annually
    Sales Status: Open
    Minimum Investment $: 500
    Subsequent Investment $: 25

    Notes:

    Resources


    Performance Analysis as of  February 28, 2017

    Growth of $10,000

    Returns and Quartile Ranking
    Calendar Returns %

    Trailing Return %

    Portfolio Analysis

    Asset Mix

    Top Ten Holdings
    Top Ten Holdings % Assets
    Apple Inc 10.1
    Microsoft Corp 7.3
    Alphabet Inc A 7.3
    Facebook Inc A 4.6
    Johnson & Johnson 4.1
    Pfizer Inc 3.0
    Visa Inc Class A 2.6
    UnitedHealth Group Inc 2.5
    Cisco Systems Inc 2.3
    Merck & Co Inc 2.1
    % Assets
    Total % of Top Ten Holdings 45.9
    Total Number of Stock Holdings 87
    Total Number of Bond Holdings 0
    Total Number of Other Holdings 1
    Total Number of Holdings 88
    Equity Style
    Statistics
    P/B Ratio 3.9
    P/E Ratio 21.1
    Avg. Mkt Cap. $Bil 183.6
    Global Equity Sectors
    % Equity
    Information Technology 64.1
    Health Care 35.9